Collegium Pharmaceutical

Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of proprietary, late stage pharmaceutical products. These products address the growing problems associated with non-medical use and abuse of prescription drugs through formulation based improvements protected by intellectual property (IP). Collegium is focused on building a portfolio of products for the treatment of chronic pain that possess tamper-resistant features and provide extended-release delivery using its patent protected DETERx™ formulation platform.
Type
Public
HQ
Cumberland, US
Founded
2002
Employees
184 (est)
Collegium Pharmaceutical was founded in 2002 and is headquartered in Cumberland, US

Key People at Collegium Pharmaceutical

Michael T. Heffernan

Michael T. Heffernan

Co - Founder, President & CEO
Heow Tan

Heow Tan

Vice President of Technical Operations
Michael Heffernan

Michael Heffernan

Co-Founder, President, CEO

Collegium Pharmaceutical Locations

Cumberland, US

Collegium Pharmaceutical Metrics

Collegium Pharmaceutical Summary

Market capitalization

$380 M

Closing share price

$16.7
Collegium Pharmaceutical's latest market capitalization is $380 M.

Collegium Pharmaceutical Market Value History

Collegium Pharmaceutical Company Life

You may also be interested in